BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19372545)

  • 1. AMP-activated protein kinase promotes human prostate cancer cell growth and survival.
    Park HU; Suy S; Danner M; Dailey V; Zhang Y; Li H; Hyduke DR; Collins BT; Gagnon G; Kallakury B; Kumar D; Brown ML; Fornace A; Dritschilo A; Collins SP
    Mol Cancer Ther; 2009 Apr; 8(4):733-41. PubMed ID: 19372545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
    Roca H; Varsos ZS; Pienta KJ
    Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.
    Chhipa RR; Wu Y; Mohler JL; Ip C
    Cell Signal; 2010 Oct; 22(10):1554-61. PubMed ID: 20570728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.
    Zhou J; Huang W; Tao R; Ibaragi S; Lan F; Ido Y; Wu X; Alekseyev YO; Lenburg ME; Hu GF; Luo Z
    Oncogene; 2009 May; 28(18):1993-2002. PubMed ID: 19347029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
    Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
    PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
    Penfold L; Woods A; Muckett P; Nikitin AY; Kent TR; Zhang S; Graham R; Pollard A; Carling D
    Cancer Res; 2018 Dec; 78(24):6747-6761. PubMed ID: 30242113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia.
    Chhipa RR; Wu Y; Ip C
    Cell Signal; 2011 Sep; 23(9):1466-72. PubMed ID: 21554950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
    Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy stores.
    Patel VA; Massenburg D; Vujicic S; Feng L; Tang M; Litbarg N; Antoni A; Rauch J; Lieberthal W; Levine JS
    J Biol Chem; 2015 Sep; 290(37):22352-69. PubMed ID: 26183782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).
    Draz H; Goldberg AA; Titorenko VI; Tomlinson Guns ES; Safe SH; Sanderson JT
    Cell Signal; 2017 Dec; 40():172-182. PubMed ID: 28923415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
    Santha S; Viswakarma N; Das S; Rana A; Rana B
    J Biol Chem; 2015 Sep; 290(36):21865-75. PubMed ID: 26198640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway.
    Johnson JJ; Syed DN; Heren CR; Suh Y; Adhami VM; Mukhtar H
    Pharm Res; 2008 Sep; 25(9):2125-34. PubMed ID: 18286356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.
    Yun H; Lee M; Kim SS; Ha J
    J Biol Chem; 2005 Mar; 280(11):9963-72. PubMed ID: 15640157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pentacyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces apoptotic death in prostate cancer cells.
    Akhtar N; Syed DN; Khan MI; Adhami VM; Mirza B; Mukhtar H
    Oncotarget; 2016 Jan; 7(4):3819-31. PubMed ID: 26683363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.
    Zakikhani M; Dowling RJ; Sonenberg N; Pollak MN
    Cancer Prev Res (Phila); 2008 Oct; 1(5):369-75. PubMed ID: 19138981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.
    Sun A; Li C; Chen R; Huang Y; Chen Q; Cui X; Liu H; Thrasher JB; Li B
    Prostate; 2016 Feb; 76(2):172-83. PubMed ID: 26440826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
    Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
    J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase antagonizes pro-apoptotic extracellular signal-regulated kinase activation by inducing dual-specificity protein phosphatases in response to glucose deprivation in HCT116 carcinoma.
    Kim MJ; Park IJ; Yun H; Kang I; Choe W; Kim SS; Ha J
    J Biol Chem; 2010 May; 285(19):14617-27. PubMed ID: 20220132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
    Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
    Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.